|
US4190659A
(en)
*
|
1973-08-27 |
1980-02-26 |
Sandoz, Inc. |
Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
|
|
US4187309A
(en)
*
|
1977-06-20 |
1980-02-05 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
|
US4281131A
(en)
|
1977-06-20 |
1981-07-28 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
|
|
US4273930A
(en)
*
|
1977-06-20 |
1981-06-16 |
Sandoz, Inc. |
4-Hydroxy-2-quinolinone-3-carboxylic acid esters
|
|
US4221797A
(en)
*
|
1978-08-14 |
1980-09-09 |
Sandoz, Inc. |
Dihydroquinoline-one derivatives
|
|
FR2443467A1
(fr)
*
|
1978-12-08 |
1980-07-04 |
Roussel Uclaf |
Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
|
|
FR2482596A1
(fr)
*
|
1980-05-19 |
1981-11-20 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament
|
|
US4266050A
(en)
*
|
1980-07-02 |
1981-05-05 |
American Home Products Corporation |
1,2-Dihydro-4-hydroxy-2-imino-N-substituted-3-quinolinecarboxamide derivatives
|
|
IE52670B1
(en)
|
1981-03-03 |
1988-01-20 |
Leo Ab |
Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
|
|
FR2523130A1
(fr)
*
|
1982-03-15 |
1983-09-16 |
Roussel Uclaf |
Nouveaux derives de la n-dihydrothiazolyl-3-quinoleine carboxamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
FR2507602A1
(fr)
*
|
1981-06-12 |
1982-12-17 |
Roussel Uclaf |
Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
HU190796B
(en)
*
|
1981-06-12 |
1986-11-28 |
Roussel Uclaf,Fr |
Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
|
|
FR2509728A1
(fr)
*
|
1981-07-17 |
1983-01-21 |
Roussel Uclaf |
Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
|
|
FR2537139B2
(fr)
*
|
1982-03-15 |
1985-09-20 |
Roussel Uclaf |
Nouveau derive de la n-dihydrothiazolyl 3-quinoleine carboxamide, procede de preparation, application a titre de medicament et compositions le renfermant
|
|
FR2551437B2
(fr)
*
|
1982-06-03 |
1985-10-25 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-oh 3-quinoleine carboxylique substitues en 2, nouveau procede de preparation, leur application comme medicament et les compositions les renfermant et produits necessaires a leur preparation
|
|
FR2530633A1
(fr)
*
|
1982-06-03 |
1984-01-27 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
|
|
FR2532939A1
(fr)
*
|
1982-09-13 |
1984-03-16 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
|
|
FR2537140B1
(fr)
*
|
1982-12-07 |
1986-07-18 |
Roussel Uclaf |
Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
|
|
SE452170B
(sv)
*
|
1983-10-03 |
1987-11-16 |
Boliden Ab |
Forfarande for utvinning av metall ur koppar och/eller edelmetall innehallande material som innehaller antimon och vismut
|
|
FR2566405B1
(fr)
*
|
1984-06-25 |
1986-09-26 |
Roussel Uclaf |
Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
|
|
US4602014A
(en)
*
|
1984-07-09 |
1986-07-22 |
Ciba-Geigy Corporation |
Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
|
|
JPH0358559A
(ja)
*
|
1989-07-26 |
1991-03-13 |
Sekisui Chem Co Ltd |
電話システム
|
|
DE69128481T2
(de)
*
|
1990-09-07 |
1998-04-09 |
Schering Corp |
Antivirale und antihypertensive verbindungen
|
|
US5175151A
(en)
*
|
1990-09-07 |
1992-12-29 |
Schering Corporation |
Antiviral compounds and antihypertensive compounds
|
|
US5179093A
(en)
*
|
1991-05-10 |
1993-01-12 |
Schering Corporation |
Quinoline-diones
|
|
DE4138820A1
(de)
*
|
1991-11-26 |
1993-05-27 |
Basf Ag |
Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
|
|
SE9201076L
(sv)
*
|
1992-04-06 |
1993-10-07 |
Shimon Slavin |
Användningen av gamla läkemedel för behandling av diabetes
|
|
SE9400810D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of Quinoline-3-carboxamide compounds
|
|
SE9400809D0
(sv)
*
|
1994-03-10 |
1994-03-10 |
Pharmacia Ab |
New use of quinoline-3-carboxamide compounds
|
|
TWI328009B
(en)
*
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
|
SE0400235D0
(sv)
*
|
2004-02-06 |
2004-02-06 |
Active Biotech Ab |
New composition containing quinoline compounds
|
|
US8314124B2
(en)
*
|
2004-02-06 |
2012-11-20 |
Active Biotech Ab |
Crystalline salts of quinoline compounds and methods for preparing them
|
|
US8354427B2
(en)
*
|
2004-06-24 |
2013-01-15 |
Vertex Pharmaceutical Incorporated |
Modulators of ATP-binding cassette transporters
|
|
RU2528046C2
(ru)
*
|
2004-06-24 |
2014-09-10 |
Вертекс Фармасьютикалз Инкорпорейтед |
Модуляторы транспортеров атф-связывающей кассеты
|
|
PL2489659T3
(pl)
*
|
2004-06-24 |
2018-06-29 |
Vertex Pharma |
Modulatory transporterów posiadających kasetę wiążącą atp
|
|
WO2006087830A1
(ja)
*
|
2005-02-18 |
2006-08-24 |
Kanebo, Ltd. |
帯状織物構造体およびその製法
|
|
CN107176923A
(zh)
*
|
2005-10-19 |
2017-09-19 |
泰华制药工业有限公司 |
拉奎尼莫钠晶体及其制备方法
|
|
EP1979367A2
(en)
*
|
2005-12-24 |
2008-10-15 |
Vertex Pharmaceuticals Incorporated |
Quinolin-4-one derivatives as modulators of abc transporters
|
|
PT1993360T
(pt)
|
2005-12-28 |
2017-05-25 |
Vertex Pharma |
Formas sólidas de n-[2,4-bis(1,1-dimetiletil)-5-hidroxifenil]-1,4-di-hidro-4-oxoquinolina-3-carboxamida
|
|
KR101495327B1
(ko)
|
2006-06-12 |
2015-02-24 |
테바 파마슈티컬 인더스트리즈 리미티드 |
안정한 라퀴니모드 제제
|
|
WO2008097976A1
(en)
*
|
2007-02-09 |
2008-08-14 |
Kalypsys, Inc. |
Heterocyclic modulators of tgr5 for treatment of disease
|
|
US8178127B2
(en)
|
2007-12-20 |
2012-05-15 |
Teva Pharmaceuticals Industries, Ltd. |
Stable laquinimod preparations
|
|
US12458635B2
(en)
|
2008-08-13 |
2025-11-04 |
Vertex Pharmaceuticals Incorporated |
Pharmaceutical composition and administrations thereof
|
|
US20100074949A1
(en)
|
2008-08-13 |
2010-03-25 |
William Rowe |
Pharmaceutical composition and administration thereof
|
|
CA2736091A1
(en)
*
|
2008-09-03 |
2010-03-11 |
Teva Pharmaceutical Industries Ltd. |
2-oxo-1,2-dihydro-quinoline modulators of immune function
|
|
EP3330255B1
(en)
|
2009-03-20 |
2020-12-09 |
Vertex Pharmaceuticals Incorporated |
Process for making modulators of cystic fibrosis transmembrane conductance regulator
|
|
CN105616410A
(zh)
*
|
2009-07-30 |
2016-06-01 |
泰华制药工业有限公司 |
利用拉喹莫德治疗克隆氏病
|
|
ES2731052T3
(es)
*
|
2009-08-10 |
2019-11-13 |
Active Biotech Ab |
Tratamiento de la enfermedad de Huntington usando laquinimod
|
|
KR20150135552A
(ko)
*
|
2010-03-03 |
2015-12-02 |
테바 파마슈티컬 인더스트리즈 리미티드 |
라퀴니모드를 이용한 루푸스 신장염의 치료
|
|
WO2011109531A1
(en)
*
|
2010-03-03 |
2011-09-09 |
Teva Pharmaceutical Industries Ltd. |
Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
|
|
SG183515A1
(en)
*
|
2010-03-03 |
2012-10-30 |
Teva Pharma |
Treatment of lupus arthritis using laquinimod
|
|
CN102267984B
(zh)
*
|
2010-06-04 |
2014-07-30 |
中国人民解放军军事医学科学院毒物药物研究所 |
4-羟基喹啉-3-酰胺衍生物及其制备方法和用途
|
|
KR20130065728A
(ko)
|
2010-10-14 |
2013-06-19 |
임뮤나르 에이비 |
Ahr 활성화제로서의 1,2-디히드로-4-히드록시-2-옥소-퀴놀린-3-카르복사닐리드
|
|
US8802700B2
(en)
|
2010-12-10 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Modulators of ATP-Binding Cassette transporters
|
|
EP2537517A1
(en)
*
|
2011-06-22 |
2012-12-26 |
Active Biotech AB |
Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
|
|
SG11201401330YA
(en)
|
2011-10-12 |
2014-05-29 |
Teva Pharma |
Treatment of multiple sclerosis with combination of laquinimod and fingolimod
|
|
US9161935B2
(en)
|
2012-02-03 |
2015-10-20 |
Teva Pharmaceutical Industries, Ltd. |
Use of laquinimod for treating Crohn's disease patients who failed first-line anti-TNF therapy
|
|
IL311180A
(en)
|
2012-02-27 |
2024-04-01 |
Vertex Pharma |
Pharmaceutical preparations containing a solid dispersion of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide and uses thereof
|
|
TW201400117A
(zh)
|
2012-06-05 |
2014-01-01 |
Teva Pharma |
使用拉喹莫德治療眼發炎疾病
|
|
CA2890194A1
(en)
|
2012-11-07 |
2014-05-15 |
Teva Pharmaceutical Industries Ltd. |
Amine salts of laquinimod
|
|
KR102226587B1
(ko)
*
|
2013-01-31 |
2021-03-11 |
버텍스 파마슈티칼스 인코포레이티드 |
나트륨 채널의 조절제로서의 퀴놀린 및 퀴나졸린 아미드
|
|
WO2014153145A2
(en)
|
2013-03-14 |
2014-09-25 |
Teva Pharmaceutical Industries Ltd. |
Crystals of laquinimod sodium and improved process for the manufacture thereof
|
|
UY36099A
(es)
|
2014-04-29 |
2016-02-29 |
Teva Pharma |
Laquinimod para el tratamiento de pacientes con esclerosis múltiple remitente recurrente (rrms) con un alto grado de discapacidad
|
|
CN107250113B
(zh)
|
2014-10-07 |
2019-03-29 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调节蛋白的调节剂的共晶
|